JPWO2023085432A1 - - Google Patents
Info
- Publication number
- JPWO2023085432A1 JPWO2023085432A1 JP2023559948A JP2023559948A JPWO2023085432A1 JP WO2023085432 A1 JPWO2023085432 A1 JP WO2023085432A1 JP 2023559948 A JP2023559948 A JP 2023559948A JP 2023559948 A JP2023559948 A JP 2023559948A JP WO2023085432 A1 JPWO2023085432 A1 JP WO2023085432A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/10—Aza-phenanthrenes
- C07D221/12—Phenanthridines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021185802 | 2021-11-15 | ||
| PCT/JP2022/042332 WO2023085432A1 (ja) | 2021-11-15 | 2022-11-15 | 抗ＳＡＲＳ－ＣｏＶ－２薬 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023085432A1 true JPWO2023085432A1 (https=) | 2023-05-19 |
| JPWO2023085432A5 JPWO2023085432A5 (https=) | 2025-11-26 |
Family
ID=86335915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023559948A Pending JPWO2023085432A1 (https=) | 2021-11-15 | 2022-11-15 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20250026734A1 (https=) |
| EP (1) | EP4434969A4 (https=) |
| JP (1) | JPWO2023085432A1 (https=) |
| WO (1) | WO2023085432A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024237331A1 (ja) * | 2023-05-17 | 2024-11-21 | オンコリスバイオファーマ株式会社 | フェナントリジノン誘導体のコリン塩 |
| CN118880358B (zh) * | 2024-09-02 | 2025-09-05 | 桂林医学院 | 一种电化学合成菲啶酮和螺环羟吲哚化合物的方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6958347B2 (en) * | 2002-12-18 | 2005-10-25 | Pfizer Inc. | Aminophenanthridinone and aminophenanthridine as NPY-5 antagonists |
| JPWO2011093483A1 (ja) | 2010-02-01 | 2013-06-06 | 国立大学法人 鹿児島大学 | Ｃ型肝炎治療剤 |
| EP4154884A4 (en) * | 2020-05-18 | 2024-05-29 | Oncolys BioPharma, Inc. | Anti-sars-cov-2 durg |
| JP7526592B2 (ja) | 2020-05-28 | 2024-08-01 | 株式会社シマノ | 釣竿 |
-
2022
- 2022-11-15 US US18/710,011 patent/US20250026734A1/en active Pending
- 2022-11-15 JP JP2023559948A patent/JPWO2023085432A1/ja active Pending
- 2022-11-15 EP EP22892930.3A patent/EP4434969A4/en active Pending
- 2022-11-15 WO PCT/JP2022/042332 patent/WO2023085432A1/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023085432A1 (ja) | 2023-05-19 |
| EP4434969A1 (en) | 2024-09-25 |
| EP4434969A4 (en) | 2025-11-12 |
| US20250026734A1 (en) | 2025-01-23 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251117 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20251117 |